NanoViricides
NNVC
#10453
Rank
C$50.01 M
Marketcap
C$1.96
Share price
-2.10%
Change (1 day)
-10.16%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: C$50.01 Million

As of August 2026 NanoViricides has a market cap of C$50.01 Million. This makes NanoViricides the world's 10453th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026C$50.01 M42.3%
2025C$35.14 M13.82%
2024C$30.88 M94.33%
2023C$15.89 M-9.13%
2022C$17.48 M-68%
2021C$54.63 M40%
2020C$39.02 M207.58%
2019C$12.68 M-32.99%
2018C$18.93 M-72.98%
2017C$70.08 M-16.26%
2016C$83.69 M-11.58%
2015C$94.64 M-46.99%
2014C$0.17 B-30.17%
2013C$0.25 B243.65%
2012C$74.4 M-19.71%
2011C$92.66 M-54.56%
2010C$0.20 B72.87%
2009C$0.11 B-2.38%
2008C$0.12 B160.69%
2007C$46.35 M

End of Day market cap according to different sources

On Aug 6th, 2026 the market cap of NanoViricides was reported to be:

C$49.82 Million
by Nasdaq info icon info icon
C$50.01 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$227.63 B 455,018.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$444.22 B 888,028.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$183.60 B 366,971.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$146.39 B 292,588.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$1.78 B 3,465.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$3.31 B 6,521.26%๐Ÿ‡บ๐Ÿ‡ธ USA